Roux-en-Y gastric bypass operation in rats
- PMID: 22710348
- PMCID: PMC3471289
- DOI: 10.3791/3940
Roux-en-Y gastric bypass operation in rats
Abstract
Currently, the most effective therapy for the treatment of morbid obesity to induce significant and maintained body weight loss with a proven mortality benefit is bariatric surgery. Consequently, there has been a steady rise in the number of bariatric operations done worldwide in recent years with the Roux-en-Y gastric bypass (gastric bypass) being the most commonly performed operation. Against this background, it is important to understand the physiological mechanisms by which gastric bypass induces and maintains body weight loss. These mechanisms are yet not fully understood, but may include reduced hunger and increased satiation, increased energy expenditure, altered preference for food high in fat and sugar, altered salt and water handling of the kidney as well as alterations in gut microbiota. Such changes seen after gastric bypass may at least partly stem from how the surgery alters the hormonal milieu because gastric bypass increases the postprandial release of peptide-YY (PYY) and glucagon-like-peptide-1 (GLP-1), hormones that are released by the gut in the presence of nutrients and that reduce eating. During the last two decades numerous studies using rats have been carried out to further investigate physiological changes after gastric bypass. The gastric bypass rat model has proven to be a valuable experimental tool not least as it closely mimics the time profile and magnitude of human weight loss, but also allows researchers to control and manipulate critical anatomic and physiologic factors including the use of appropriate controls. Consequently, there is a wide array of rat gastric bypass models available in the literature reviewed elsewhere in more detail. The description of the exact surgical technique of these models varies widely and differs e.g. in terms of pouch size, limb lengths, and the preservation of the vagal nerve. If reported, mortality rates seem to range from 0 to 35%. Furthermore, surgery has been carried out almost exclusively in male rats of different strains and ages. Pre- and postoperative diets also varied significantly. Technical and experimental variations in published gastric bypass rat models complicate the comparison and identification of potential physiological mechanisms involved in gastric bypass. There is no clear evidence that any of these models is superior, but there is an emerging need for standardization of the procedure to achieve consistent and comparable data. This article therefore aims to summarize and discuss technical and experimental details of our previously validated and published gastric bypass rat model.
Similar articles
-
Lessons learned from gastric bypass operations in rats.Obes Facts. 2011;4 Suppl 1(Suppl 1):3-12. doi: 10.1159/000327301. Epub 2011 Mar 31. Obes Facts. 2011. PMID: 22027283 Free PMC article. Review.
-
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.Ann Surg. 2007 Nov;246(5):780-5. doi: 10.1097/SLA.0b013e3180caa3e3. Ann Surg. 2007. PMID: 17968169 Clinical Trial.
-
GLP-1 and PYY3-36 reduce high-fat food preference additively after Roux-en-Y gastric bypass in diet-induced obese rats.Surg Obes Relat Dis. 2019 Sep;15(9):1483-1492. doi: 10.1016/j.soard.2019.04.008. Epub 2019 Apr 16. Surg Obes Relat Dis. 2019. PMID: 31548004
-
Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.Surg Obes Relat Dis. 2014 Sep-Oct;10(5):822-8. doi: 10.1016/j.soard.2014.04.018. Epub 2014 Apr 29. Surg Obes Relat Dis. 2014. PMID: 25282191
-
Is a model useful in exploring the catabolic mechanisms of weight loss after gastric bypass in humans?Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):463-74. doi: 10.1097/MCO.0b013e3281e2c9e7. Curr Opin Clin Nutr Metab Care. 2007. PMID: 17563465 Review.
Cited by
-
The physiology underlying Roux-en-Y gastric bypass: a status report.Am J Physiol Regul Integr Comp Physiol. 2014 Dec 1;307(11):R1275-91. doi: 10.1152/ajpregu.00185.2014. Epub 2014 Sep 24. Am J Physiol Regul Integr Comp Physiol. 2014. PMID: 25253084 Free PMC article. Review.
-
Roux-En-Y Gastric Bypass (RYGB) Surgery during High Liquid Sucrose Diet Leads to Gut Microbiota-Related Systematic Alterations.Int J Mol Sci. 2022 Jan 20;23(3):1126. doi: 10.3390/ijms23031126. Int J Mol Sci. 2022. PMID: 35163046 Free PMC article.
-
Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery.Diab Vasc Dis Res. 2020 Jan-Feb;17(1):1479164119879039. doi: 10.1177/1479164119879039. Epub 2019 Nov 14. Diab Vasc Dis Res. 2020. PMID: 31726864 Free PMC article.
-
Weight loss in adult male Wistar rats by Roux-en-Y gastric bypass is primarily explained by caloric intake reduction and presurgery body weight.Am J Physiol Regul Integr Comp Physiol. 2024 Jun 1;326(6):R507-R514. doi: 10.1152/ajpregu.00169.2023. Epub 2024 Apr 8. Am J Physiol Regul Integr Comp Physiol. 2024. PMID: 38586888 Free PMC article.
-
RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment.PLoS One. 2020 Dec 10;15(12):e0243640. doi: 10.1371/journal.pone.0243640. eCollection 2020. PLoS One. 2020. PMID: 33301513 Free PMC article.
References
-
- Adams TD, Gress RE, Smith SC. Long-term mortality after gastric bypass surgery. N. Engl. J. Med. 2007;357:753–761. - PubMed
-
- Sjostrom L, Lindroos AK, Peltonen M. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med. 2004;351:2683–2693. - PubMed
-
- Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide. Obes. Surg. 2008;19:1605–1611. - PubMed
-
- Welbourn R, Werling M. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann. Surg. 2007;246:780–785. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials